Hematology NewsRivaroxaban plus aspirin safely benefits PAD patients after limb revascularizationMarch 28, 2020Thrombosis
Hematology NewsAnticoagulants may have advantage over aspirin for low-risk TAVRMarch 12, 2020Thrombosis
Hematology NewsThe evolving landscape of complement inhibition therapyJanuary 21, 2020AnemiaThrombosis
Hematology NewsAre providers asking about menstrual bleeding before/during anticoagulant therapy?January 16, 2020Thrombosis
Hematology NewsBariatric surgery candidates show high prevalence of thrombophiliaJanuary 8, 2020Thrombosis
Hematology NewsNew ASH guideline: VTE prophylaxis after major surgeryDecember 12, 2019ThrombosisMixed Topics
Hematology NewsPulmonary embolism treatment teams adopted widely for complex diseaseNovember 20, 2019Thrombosis
Hematology NewsGALILEO, GALILEO 4D: Mixed results in post-TAVR anticoagulationNovember 18, 2019Thrombosis
Hematology NewsThromboembolic events more likely among CIDP patients with CVADOctober 29, 2019Thrombosis
Hematology NewsFDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patientsOctober 15, 2019Thrombosis
Hematology NewsRivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APSOctober 15, 2019Thrombosis
Hematology NewsOlder IBD patients are most at risk of postdischarge VTESeptember 10, 2019GastroenterologyThrombosisGastrointestinal Cancer
